ICU stock icon

SeaStar Medical


About: SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Employees: 12

Funds holding %
of 6,689 funds
Analysts bullish %
News positive %
of 6 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

1,000% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 1

571% more capital invested

Capital invested by funds: $418K [Q4 2023] → $2.8M (+$2.38M) [Q1 2024]

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

21% more funds holding

Funds holding: 24 [Q4 2023] → 29 (+5) [Q1 2024]

3.64% more ownership

Funds ownership: 2.21% [Q4 2023] → 5.85% (+3.64%) [Q1 2024]

Research analyst outlook

We haven’t received any recent analyst ratings for ICU.

Financial journalist opinion

Based on 6 articles about ICU published over the past 30 days